{
  "name": "Johnson & Johnson",
  "slug": "johnson-and-johnson",
  "ticker": "JNJ",
  "fetched_at": "2025-12-12T12:25:09.896319+00:00",
  "news": [
    {
      "title": "The Bull Case For Johnson & Johnson (JNJ) Could Change Following New Multiple Myeloma Breakthrough Data - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPRFFkY2N2Nmw0RjJPZ3JqUXViOFNDMmVXbWxoOEk5XzZEQTNjUDFKUC1xQVhLOHZqb1FFN2VLdHhsU19Zb0g0UHE4aU1wUXJwTWx6U3RNcGxvbF80YzJpTTZQNE9PY3dvVmpmQzRrbG1iRHpiZ3JCSWFHTUxqMDJMTw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxPRFFkY2N2Nmw0RjJPZ3JqUXViOFNDMmVXbWxoOEk5XzZEQTNjUDFKUC1xQVhLOHZqb1FFN2VLdHhsU19Zb0g0UHE4aU1wUXJwTWx6U3RNcGxvbF80YzJpTTZQNE9PY3dvVmpmQzRrbG1iRHpiZ3JCSWFHTUxqMDJMTw?oc=5\" target=\"_blank\">The Bull Case For Johnson & Johnson (JNJ) Could Change Following New Multiple Myeloma Breakthrough Data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-11T08:12:39+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Johnson & Johnson: Reliable Cash Flows, Moderate Expectations - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPNHVxQ0I0MTgyUnVaWVh0ZFJ0alZ2cF9CMl94Tl9JcHdzek5FRE1RTi0tYURPNkxoNlA3ZXRLZ3dZbEYteDlkc2laMkxxT3EwbGo5dG1kcWhqSXh6VnJFS1VheW1XcXplVGhTekNhQTJPLWtWdHNGYnlFSjJiYXNneE9LYTMyVnE3OVRJYm5Ob3pTUnNkYkVHOTUtQlFyaVdnSmh0Tg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxPNHVxQ0I0MTgyUnVaWVh0ZFJ0alZ2cF9CMl94Tl9JcHdzek5FRE1RTi0tYURPNkxoNlA3ZXRLZ3dZbEYteDlkc2laMkxxT3EwbGo5dG1kcWhqSXh6VnJFS1VheW1XcXplVGhTekNhQTJPLWtWdHNGYnlFSjJiYXNneE9LYTMyVnE3OVRJYm5Ob3pTUnNkYkVHOTUtQlFyaVdnSmh0Tg?oc=5\" target=\"_blank\">Johnson & Johnson: Reliable Cash Flows, Moderate Expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-12T00:05:02+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "J&J joins ‘menin party’ at ASH; GSK to work with Oxford BioTherapeutics - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMic0FVX3lxTE9xZldoLTh4eU9YUEpCdTFfdjIwcDVYSUl5dVphUTlxb0x5UUl6aTdUd1J3S2pNb25ITFZPZ1BIWDJJNkNkTTI2Yk5SaVhKbTM2NEotcGFMc2Z3d1lYdHdydFZRRzRoSW9YUXhGTnZwelUzdkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE9xZldoLTh4eU9YUEpCdTFfdjIwcDVYSUl5dVphUTlxb0x5UUl6aTdUd1J3S2pNb25ITFZPZ1BIWDJJNkNkTTI2Yk5SaVhKbTM2NEotcGFMc2Z3d1lYdHdydFZRRzRoSW9YUXhGTnZwelUzdkU?oc=5\" target=\"_blank\">J&amp;J joins ‘menin party’ at ASH; GSK to work with Oxford BioTherapeutics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-12-10T15:34:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Johnson & Johnson INHANCE INTACT System, USA - Medical Device Network",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQNFR2UlRGbWpmbnE3eEZPejcyUGVwSjlpUE83N0xWWDVWc0NnYzc3MjQ5bklZVV9aQmo1a3BMVnJrYVpGbVFmckQzNlpaTVNfMVlxeGtSaGNndV9iOG0tS25SaGJiQmJpeGxSUGtlbXpkV2lraG5zdTdZNnVlSktHbk5paGM5ZDdtVjJuRV9GRUo4R0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQNFR2UlRGbWpmbnE3eEZPejcyUGVwSjlpUE83N0xWWDVWc0NnYzc3MjQ5bklZVV9aQmo1a3BMVnJrYVpGbVFmckQzNlpaTVNfMVlxeGtSaGNndV9iOG0tS25SaGJiQmJpeGxSUGtlbXpkV2lraG5zdTdZNnVlSktHbk5paGM5ZDdtVjJuRV9GRUo4R0E?oc=5\" target=\"_blank\">Johnson & Johnson INHANCE INTACT System, USA</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Medical Device Network</font>",
      "published": "2025-12-11T03:42:57+00:00",
      "source": "Medical Device Network"
    },
    {
      "title": "J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQZGhDaGlqa05LY1VlS3E2YU9SekdoZnFwUnVTcXloZjJiRlo2RVhDZlpxcENiTFo1aXlsand3dU5Ka0ZTc05KVFFDdG9Zazl2bTVHRGZTUmdHaW5RUUxJZmxqT05GMk4wZXIycHNQMXZqVlRVZnVzajlvWnBmeF9QWjlfUVBYb3V1YVVkS1FyVTRVbThsVzVsMlZVUkRCZ3l2THJ1bGp6Y3A?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQZGhDaGlqa05LY1VlS3E2YU9SekdoZnFwUnVTcXloZjJiRlo2RVhDZlpxcENiTFo1aXlsand3dU5Ka0ZTc05KVFFDdG9Zazl2bTVHRGZTUmdHaW5RUUxJZmxqT05GMk4wZXIycHNQMXZqVlRVZnVzajlvWnBmeF9QWjlfUVBYb3V1YVVkS1FyVTRVbThsVzVsMlZVUkRCZ3l2THJ1bGp6Y3A?oc=5\" target=\"_blank\">J&amp;J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-12-09T12:38:21+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPNG5DUFpwMThPeS1tYTQ1bHRLUjJmREJPMVZad2RFa3Z0M0pSR3VkZnVqMW5BRWEtTTBwemJxVkFJcFpyWll4b3E5RmFIUnMzTWN2bjVfOW0wb2FyS0VfNm1rZ1RUdTNyNG5iOFJ5YVF1Q2R2amNidXlaTFBfWnc4MkhOdGVTNUhwQVFFMkQxR2otNFlPSVJTOUZMclNWSDdLTWdBeEZzdTNZSTVySF9TZA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxPNG5DUFpwMThPeS1tYTQ1bHRLUjJmREJPMVZad2RFa3Z0M0pSR3VkZnVqMW5BRWEtTTBwemJxVkFJcFpyWll4b3E5RmFIUnMzTWN2bjVfOW0wb2FyS0VfNm1rZ1RUdTNyNG5iOFJ5YVF1Q2R2amNidXlaTFBfWnc4MkhOdGVTNUhwQVFFMkQxR2otNFlPSVJTOUZMclNWSDdLTWdBeEZzdTNZSTVySF9TZA?oc=5\" target=\"_blank\">ASH: J&amp;J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-09T12:30:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "J&J’s two-drug combo blocked tumors in advanced multiple myeloma - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPemdWbklXWkZmLThfZ2s4a0kzQnphYkpFUmhKYm9Dd3JMTU8yRVJIWDZPcXpEcDVaa211X09QQzhtUWtZNG4zYm9UbzNYU1RUVWtsako1UG9iU0FscTVaRHEwbkc2SDhqYUxIWTVmR1QtdXVZR3pVejVJT013NzJkN3UyQ3NJOWc5bEFLUHduM0NFdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxPemdWbklXWkZmLThfZ2s4a0kzQnphYkpFUmhKYm9Dd3JMTU8yRVJIWDZPcXpEcDVaa211X09QQzhtUWtZNG4zYm9UbzNYU1RUVWtsako1UG9iU0FscTVaRHEwbkc2SDhqYUxIWTVmR1QtdXVZR3pVejVJT013NzJkN3UyQ3NJOWc5bEFLUHduM0NFdw?oc=5\" target=\"_blank\">J&amp;J’s two-drug combo blocked tumors in advanced multiple myeloma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-12-09T17:12:18+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNdzNsaGhYa21YT0hxWUJkSVlGZnR6SGhocFFCcEhobkt0WktwQmV0Q19QT3ZGdzlGQmVWbHdlQ3NEY25sVlNjdEF3OVN0Q0U4b2lmcTFPczAzMHFhX0dNUnp1MldNUEdjZVhBY0lxaUNPNno2ODRmU0s3ZFpIWGR2WDZTNGZDdFRhcTNN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNdzNsaGhYa21YT0hxWUJkSVlGZnR6SGhocFFCcEhobkt0WktwQmV0Q19QT3ZGdzlGQmVWbHdlQ3NEY25sVlNjdEF3OVN0Q0U4b2lmcTFPczAzMHFhX0dNUnp1MldNUEdjZVhBY0lxaUNPNno2ODRmU0s3ZFpIWGR2WDZTNGZDdFRhcTNN?oc=5\" target=\"_blank\">Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-10T16:28:40+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "J&J Gears Up for Some Key New Drug Approvals and Launches - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMickFVX3lxTFBPdUhoMFBEX2lXRzlVb3RUZ1daZkw2Ukt4TEFDSk54S0lrenk5UjNtanp5bXB5YXZiRTBXckFpWkxON0pSYnN5MERDQ3VZY0NNS1A5clE2cndiX3FUdGtkRWx3Zk5faEJoNFBmZ0JGb1FfZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMickFVX3lxTFBPdUhoMFBEX2lXRzlVb3RUZ1daZkw2Ukt4TEFDSk54S0lrenk5UjNtanp5bXB5YXZiRTBXckFpWkxON0pSYnN5MERDQ3VZY0NNS1A5clE2cndiX3FUdGtkRWx3Zk5faEJoNFBmZ0JGb1FfZw?oc=5\" target=\"_blank\">J&amp;J Gears Up for Some Key New Drug Approvals and Launches</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-03T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5\" target=\"_blank\">Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-07-29T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Johnson & Johnson MedTech advances surgical robotics with Nvidia AI, plans 2026 launch - MassDevice",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOSVBnTDMtMjloT1hrVzZjNDd5bXVlcUVoWk5aTGtRQjIxaE9vQlQyRHN1aElUQThNcl9hbHRIRU5DRkYyaDUyZlRrb1FyejRrX2QyS3ZTM0dWUTlVZjF2OGZ1SVhBNWI1WVdmaW9GdGVsX0kzXzhpVWV4S1pIMFg1QmE5OVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxOSVBnTDMtMjloT1hrVzZjNDd5bXVlcUVoWk5aTGtRQjIxaE9vQlQyRHN1aElUQThNcl9hbHRIRU5DRkYyaDUyZlRrb1FyejRrX2QyS3ZTM0dWUTlVZjF2OGZ1SVhBNWI1WVdmaW9GdGVsX0kzXzhpVWV4S1pIMFg1QmE5OVE?oc=5\" target=\"_blank\">Johnson & Johnson MedTech advances surgical robotics with Nvidia AI, plans 2026 launch</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MassDevice</font>",
      "published": "2025-10-28T07:00:00+00:00",
      "source": "MassDevice"
    },
    {
      "title": "Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst - Johnson & Johnson (NYSE:JNJ) - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOQTFyVGpMbjFLSUJ0TzFDTkRrbXlnQWh0TDYyNjBVM2htMDFoRHNhTWRoWWhWeWR6bTZYVjVrWnlCdkl4LTNUek9PRU5oXzZyUlJQaVVlMzAtSDFBajdleFBhTTVzc3k4bVE3MVlGb3JpU0dPX1Y2ZklDMHR1WlpLWUFQTndKa2NXQ2UtTkRZYVN1bV91V0E5MjFhYllqYk5iSy16RHNWd2w0MHhKOHNNY3lBb0pNaDBxNWhkTjF5b3dkTVlrQldtZ1l2SG5wTXBKN0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOQTFyVGpMbjFLSUJ0TzFDTkRrbXlnQWh0TDYyNjBVM2htMDFoRHNhTWRoWWhWeWR6bTZYVjVrWnlCdkl4LTNUek9PRU5oXzZyUlJQaVVlMzAtSDFBajdleFBhTTVzc3k4bVE3MVlGb3JpU0dPX1Y2ZklDMHR1WlpLWUFQTndKa2NXQ2UtTkRZYVN1bV91V0E5MjFhYllqYk5iSy16RHNWd2w0MHhKOHNNY3lBb0pNaDBxNWhkTjF5b3dkTVlrQldtZ1l2SG5wTXBKN0E?oc=5\" target=\"_blank\">Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst - Johnson & Johnson (NYSE:JNJ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Earnings call transcript: Johnson & Johnson Q3 2025 earnings beat forecast - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQRGQ2TExYZFNUaW82U0hvWWp6MEhIeDhCQWxiX2UzVW1fSzJud3JjQ3NFcXl1RU85cDJ0dURxbnFmRHEta2VKLWE0cDdONjZIUkZLdXlaRDc5TkRtMFhNN0dMTHpNbGpFc2RXSnEzU1FELTc3R3JfblU1U01xa3JVOHk2a2NhWV9aQ0UzVndqR0tOY28wN1JMZ1hMRWdULWtCd29pRTVpX01rMENoZGY0TjFnNDAwNVhWck5xYmdTTzFySjNaMFlJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQRGQ2TExYZFNUaW82U0hvWWp6MEhIeDhCQWxiX2UzVW1fSzJud3JjQ3NFcXl1RU85cDJ0dURxbnFmRHEta2VKLWE0cDdONjZIUkZLdXlaRDc5TkRtMFhNN0dMTHpNbGpFc2RXSnEzU1FELTc3R3JfblU1U01xa3JVOHk2a2NhWV9aQ0UzVndqR0tOY28wN1JMZ1hMRWdULWtCd29pRTVpX01rMENoZGY0TjFnNDAwNVhWck5xYmdTTzFySjNaMFlJ?oc=5\" target=\"_blank\">Earnings call transcript: Johnson & Johnson Q3 2025 earnings beat forecast</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-10-14T07:00:00+00:00",
      "source": "Investing.com"
    }
  ],
  "stock": {
    "ticker": "JNJ",
    "currency": "USD",
    "latest": {
      "date": "2025-12-11",
      "close": 210.00999450683594
    },
    "history": [
      {
        "date": "2025-12-03",
        "close": 205.3300018310547
      },
      {
        "date": "2025-12-04",
        "close": 202.47999572753906
      },
      {
        "date": "2025-12-05",
        "close": 201.92999267578125
      },
      {
        "date": "2025-12-08",
        "close": 201.6199951171875
      },
      {
        "date": "2025-12-09",
        "close": 199.9600067138672
      },
      {
        "date": "2025-12-10",
        "close": 206.5399932861328
      },
      {
        "date": "2025-12-11",
        "close": 210.00999450683594
      }
    ],
    "name": "Johnson & Johnson"
  }
}